A Study to Evaluate Emapalumab in Japanese Healthy Volunteers.
Status:
Completed
Trial end date:
2021-07-25
Target enrollment:
Participant gender:
Summary
This is a randomized, placebo controlled and double-blinded study to evaluate the
pharmacokinetics (PK), pharmacodynamics (PD) and safety of a single dose (1 mg/kg) of
emapalumab in adult healthy Japanese subjects.